TY - JOUR T1 - Medical benefits JF - British Journal of General Practice JO - Br J Gen Pract SP - 886 LP - 886 VL - 55 IS - 520 AU - Steve Iliffe Y1 - 2005/11/01 UR - http://bjgp.org/content/55/520/886.1.abstract N2 - Alec Logan is wise to warn against collusion with commercial interests and misplaced hopes in the benefits of medication.1 But what about avoiding the risks of a highly selective review of the scientific evidence about medication? By citing only AD2000 and the Petersen study of mild cognitive impairment he confuses two issues. There are many trials of cholinesterase inhibitors in Alzheimer's disease, all of which are methodologically limited (AD2000 included), and MCI is not the same as Alzheimer's disease — some would argue that … ER -